UM  > Faculty of Health Sciences
Residential Collegefalse
Status已發表Published
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
WANG LI
2022-03
Source PublicationMedicinal Research Reviews
Volume42Issue:2Pages:946-982
Abstract

Glycogen synthase kinase-3 (GSK3) is a highly evolutionarily conserved serine/threonine protein kinase first identified as an enzyme that regulates glycogen synthase (GS) in response to insulin stimulation, which involves GSK3 regulation of glucose metabolism and energy homeostasis. Both isoforms of GSK3, GSK3α, and GSK3β, have been implicated in many biological and pathophysiological processes. The various functions of GSK3 are indicated by its widespread distribution in multiple cell types and tissues. The studies of GSK3 activity using animal models and the observed effects of GSK3-specific inhibitors provide more insights into the roles of GSK3 in regulating energy metabolism and homeostasis. The cross-talk between GSK3 and some important energy regulators and sensors and the regulation of GSK3 in mitochondrial activity and component function further highlight the molecular mechanisms in which GSK3 is involved to regulate the metabolic activity, beyond its classical regulatory effect on GS. In this review, we summarize the specific roles of GSK3 in energy metabolism regulation in tissues that are tightly associated with energy metabolism and the functions of GSK3 in the development of metabolic disorders. We also address the impacts of GSK3 on the regulation of mitochondrial function, activity and associated metabolic regulation. The application of GSK3 inhibitors in clinical tests will be highlighted too. Interactions between GSK3 and important energy regulators and GSK3-mediated responses to different stresses that are related to metabolism are described to provide a brief overview of previously less-appreciated biological functions of GSK3 in energy metabolism and associated diseases through its regulation of GS and other functions.

DOI10.1002/med.21867
URLView the original
Indexed BySCIE
Language英語English
WOS IDWOS:000713972300001
Scopus ID2-s2.0-85118484014
Fulltext Access
Citation statistics
Cited Times [WOS]:75   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionFaculty of Health Sciences
Affiliation1.Department of Biological Sciences,Faculty of Health Sciences,University of Macau,Macau,China
2.Cancer Center,Faculty of Health Sciences,University of Macau,Macau,China
3.Institute of Translational Medicine,Faculty of Health Sciences,University of Macau,Macau,China
Recommended Citation
GB/T 7714
WANG LI. Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases[J]. Medicinal Research Reviews, 2022, 42(2), 946-982.
APA WANG LI.(2022). Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases. Medicinal Research Reviews, 42(2), 946-982.
MLA WANG LI."Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases".Medicinal Research Reviews 42.2(2022):946-982.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[WANG LI]'s Articles
Baidu academic
Similar articles in Baidu academic
[WANG LI]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[WANG LI]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.